Abiopharma

🔍 Lampropoulos Fred P. (Executive)

Company: MERIT MEDICAL SYSTEMS INC (MMSI)

Report Date: 2025-08-29

Detailed Transactions and Holdings:

• Acquired 159,151 shares of Common Stock, No Par Value at $55.73 per share (Direct)
  Date: 2025-08-29 | Code: M | equity_swap_involved: 1 | shares_owned_after: 1,204,779.00 | transaction_form_type: 4
• Sold 124,824 shares of Common Stock, No Par Value at $90.54 per share (Direct)
  Date: 2025-08-29 | Code: F | equity_swap_involved: 1 | shares_owned_after: 1,079,955.00 | transaction_form_type: 4 | Footnotes: F3
• Acquired 2,000 shares of Common Stock, No Par Value at $55.73 per share (Direct)
  Date: 2025-08-29 | Code: M | equity_swap_involved: 1 | shares_owned_after: 9,734.26 | transaction_form_type: 4 | Footnotes: F2
• Sold 1,454 shares of Common Stock, No Par Value at $90.54 per share (Direct)
  Date: 2025-08-29 | Code: F | equity_swap_involved: 1 | shares_owned_after: 8,280.26 | transaction_form_type: 4 | Footnotes: F4
• Holds 0 shares of Common Stock, No Par Value (Direct)
  Date: 2025-08-29 | Code: H | nature_of_ownership: By 401(k) Plan | shares_owned_after: 97,909.00 | Footnotes: F1
• Holds 0 shares of Common Stock, No Par Value (Direct)
  Date: 2025-08-29 | Code: H | nature_of_ownership: By spouse as custodian for child | shares_owned_after: 90.00 | Footnotes: F2
• Sold 159,151 shares of Non-qualified stock options (right to buy) at $55.73 per share (Derivative)
  Date: 2025-08-29 | Code: M | Expires: 2026-03-01 | Exercise: 2020-03-01 | equity_swap_involved: 1 | transaction_form_type: 4 | Footnotes: F5
• Sold 2,000 shares of Non-qualified stock options (right to buy) at $55.73 per share (Derivative)
  Date: 2025-08-29 | Code: M | Expires: 2026-03-01 | Exercise: 2020-03-01 | equity_swap_involved: 1 | transaction_form_type: 4 | Footnotes: F6, F2
• Holds 100,334 shares of Non-qualified stock options (right to buy) at $37.71 per share (Derivative)
  Date: 2025-08-29 | Code: H | Expires: 2027-02-26 | Exercise: 2021-02-26 | shares_owned_after: 100,334.00 | Footnotes: F7
• Holds 58,083 shares of Non-qualified stock options (right to buy) at $56.25 per share (Derivative)
  Date: 2025-08-29 | Code: H | Expires: 2028-03-19 | Exercise: 2022-03-19 | shares_owned_after: 58,083.00 | Footnotes: F8
• Holds 54,302 shares of Non-qualified stock options (right to buy) at $70.58 per share (Derivative)
  Date: 2025-08-29 | Code: H | Expires: 2030-02-28 | Exercise: 2024-02-28 | shares_owned_after: 54,302.00 | Footnotes: F9

Footnotes:

• F1: The 401(k) number represents plan holdings as of 08/29/2025.
• F2: Represents securities held by the spouse of the Reporting Person. The Reporting Person expressly disclaims beneficial ownership of the securities owned by his spouse.
• F3: The Reporting Person surrendered 124,824 shares of common stock to the Issuer for payroll taxes and payment of the option price. No shares were sold in the open market.
• F4: The Reporting Person's spouse surrendered 1,454 shares of common stock to the Issuer for payroll taxes and payment of the option price. No shares were sold in the open market.
• F5: Becomes exercisable in equal annual installments of 20% commencing 3/1/2020.
• F6: Original grant of 10,000 options was to become vested and exercisable in equal annual installments of 20% commencing 3/1/2020. Options not vested as of 6/22/2020 have been forfeited.
• F7: Becomes exercisable in equal annual installments of 25% commencing 2/26/2021.
• F8: Becomes exercisable in equal annual installments of 25% commencing 3/19/2022.
• F9: Becomes exercisable in equal annual installments of 25% commencing 2/28/2024.